Persistent Diastolic Function Decline Noted With Contemporary Breast Cancer
Investigators evaluated the impact doxorubicin and/or trastuzumab have on diastolic function and the association between diastolic function and systolic dysfunction.
All articles by Cardiology Advisor Contributing Writer
Coronary Calcification an Underused CV Risk Marker Following Cancer Treatment
Despite its availability as a risk marker for cardiovascular disease, action is rarely taken to address coronary artery calcification among those who have been treated for cancer with potentially cardiotoxic regimens.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...